EZH2 and melanoma: In order to investigate the potential predictive value of H3K27me3 and EZH2 expression concerning responses to ICB, we analyzed their expression patterns in melanoma metastases of 44 patients biopsied before the start of an immunotherapy with an anti-PD-1 antibody.